- Health Occupations - Pharmacists - Disclosure of Price and Cost Share for Prescription Drugs
- Sponsored by
- Delegates Shetty, Attar, Atterbeary, Bagnall, Cox, Ebersole, W. Fisher, Fraser-Hidalgo, Healey, Hettleman, Hill, Jalisi, Johnson, Jones, Korman, R. Lewis, Moon, Palakovich Carr, Pena-Melnyk, Reznik, Smith, Solomon, Stewart, Terrasa, Valderrama, Wells, and Wilkins
- In the House - Hearing 2/12 at 1:00 p.m.
- Fiscal and Policy Note
Requiring, at the point of sale, a certain pharmacist or the pharmacist's designee to inform a retail consumer, to the best of the pharmacist's or pharmacist's designee's knowledge, of the retail price for a prescription drug and, under certain circumstances, the cost share for which the retail consumer is responsible for the prescription drug; and requiring the State Board of Pharmacy to adopt certain procedures.
Bill File Type: Regular
Effective Date(s): October 1, 2019
( 12-502 )
Last Updated: 2/3/2020 2:29 PM